Peer coaches may help heart patients navigate tough health choices
NCT ID NCT05933655
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether trained peer coaches can help people with limited health literacy discuss heart disease prevention with their doctors. Researchers will enroll 60 patients at one clinic and analyze whether coaching leads to better conversations about treatment options. The goal is to see if this approach is feasible, not yet to prove it improves health.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Peer coaching session
- What this could lead to
- If successful, this could show that peer coaching helps people with limited health literacy better discuss heart disease prevention with their doctors.
- What could go wrong
- This is a small feasibility study (60 people) at one clinic, so results may not apply broadly. It tests whether the approach works, not whether it improves health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2021
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A patient of Highland Family Medicine practice * At least 40 years old and no more than 75 years old * Be at ≥10% risk for CVD as calculated using the ASCVD Risk Estimator Plus * No plans to leave the practice in the next 12 months * English speaking * Limited Health Literacy (self-report) Exclusion Criteria: * Have experienced a prior cardiac or vascular event such as myocardial infarction (MI) or cerebrovascular accident (CVA) or have had a CVD procedure such as installation of a stent or angioplasty * Gave peripheral vascular disease, intermittent claudication or peripheral arterial disease * Lack of capacity to consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Rochester
Rochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Two eggs a day put to the test for heart health
- A soft patch that watches your heart beat in real time
- Can a Once-Daily form of tacrolimus spare liver transplant patients from side effects?
- Inhaled drug aims to ease dangerous lung blood pressure in scarred lungs
- Massive Real-World database aims to map how chronic diseases interact